When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

More than half of respondents to a survey were unaware that bariatric surgery may improve some women’s chances of getting ...

More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...

However, consumer experts are warning about hidden dangers and sneaky marketing tactics. Carl Bates with the Better Business ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

Half of UK adults say they’ve put off even trying to lose weight, with Gen Z most likely to delay  More than one in five UK adults (22%) have delayed losing weight for three years or more  Four in ...

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

Those in the jab trials, however, kept off between 10 and 25 per cent of their body weight over the same timeframe, depending ...

Often patients reach their goal weight and feel good about themselves. Then, because of the initial success, they decide the ...